Fusion of H4/D10S170 to the platelet-derived growth factor receptor β in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3592-3598

  Kulkarni, Shashikant ^a   Heath, Carol ^a   Parker, Sally ^a   Chase, Andrew ^a   Iqbal, Sameena ^a   Pocock, Christopher F ^a   Kaeda, Jaspal ^a   Cwynarski, Kate ^a   Goldman, John M ^a   Cross, Nicholas C P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GENETICS; CASE REPORT; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 5; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUSION; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; YEAST ARTIFICIAL CHROMOSOME;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 5; DROSOPHILA PROTEINS; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 18344404198     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H., Sultan, C., and Cox, C. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br. J. Haematol., 87: 746-754, 1994.
2. Martial, P., Michaux, J. L., and Rodhain, J. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia The Groupe Francais de Cytogenetique Hematologique. Blood, 78: 205-211, 1991.
3. Oscier, D. G. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br. J. Haematol., 92: 582-586, 1996.
4. Papadopoulos, P., Ridge, S. A., Boucher, C. A., Stocking, C., and Wiedemann, L. M. The novel activation of ABL by fusion to an ets-related gene. TEL. Cancer Res., 55: 34-38, 1995.
5. Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., and Marynen, P. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9:15;12) in a myeloid leukemia. Blood, 90: 2535-2540, 1997.
6. Golub, T. R., Barker, G. F., Lovett, M., and Gilliland, D. G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77: 307-316, 1994.
7. Smedley, D., Hamoudi, R., Clark, J., Warren, W., Abdul Rauf, M., Somers, G., Venter, D., Fagan, K., Cooper, C., and Shipley, J. The t(8;13)(p1;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum. Mol. Genet.. 7: 637-642, 1998.
8. Reiter, A., Sohal, J., Kulkarni, S., Chase, A., Macdonald, D. H. C., Aguiar, R. C. T., Goncalves, C., Hernandez, J. M., Jennings, B. A., Goldman, J. M., and Cross, N. C. P. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood, 92: 1735-1742, 1998.
9. Macdonald, D., Aguiar, R. C., Mason, P. J., Goldman, J. M., and Cross, N. C. P. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia (Baltimore), 9: 1628-1630, 1995.
10. Cross, N. C. P., Melo, J. V., Feng, L., and Goldman, J. M. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABI. fusion mRNAs in hematological disorders. Leukemia (Baltimore), 8: 186-189, 1994.
11. Aguiar, R. C. T., Chase, A., Coulthard, S., Macdonald, D. H., Carapeti, M., Reiter, A., Sohal, J., Lennard, A., Goldman, J. M., and Cross, N. C. P. Abnormalities of chromosome hand 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood. 90: 3130-3135, 1997.
12. Ross, T. S., Bernard, O. A., Berger, R., and Gilliland, D. G. Fusion of Huntingtin interacting protein I to platelet-derived growth factor β receptor (PDGFβR) in chronic myelonionocytic leukemia with t(5;7)(q33;q11.2). Blood, 91: 4419-4426, 1998.
13. Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T., and Saito, H. Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogcnous leukemia after clonal evolution. Blood, 90: 4271-4277, 1997.
14. Wlodarska, I., Aventin, A., Ingles Esteve, J., Falzetti, D., Criel, A., Cassiman, J. J., Mecucci, C., Van den Berghe, H., and Marynen, P. A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood, 89: 1716-1722, 1997.
15. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenhach, J. A comprehensive genetic map of the human genome based or 5.264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
16. Grieco, M., Cerrato, A., Santoro, M., Fusco, A., Melillo, R. M., and Vecchio, G. Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogcne, 9: 2531-2535, 1994.
17. Daley, G. Q., Van Etten, R. A., and Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science (Washington DC), 247: 824-830, 1990.
18. Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R., Marynen, P., and Gilliland, D. G. Transformation of hemtaopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J., 17: 5321-5333, 1998.
19. Smedley, D., Demiroglu, A., Abdul-Rauf, M., Heath, C., Cooper, C., Shipley, J., and Cross, N. C. P. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATs 1 and 5. Neoplasia, 1: 349-355, 1999.
20. Golub, T. R., Goga, A., Barker, G. F., Afar, D. E., McLaughlin, J., Bohlander, S. K., Rowley, J. D., Witte, O. N., and Gilliland, D. G. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol., 16: 4107-4116, 1996.
21. Anastasiadou, E., Schwaller, J., Sternberg, D. W., Cain, D., Grieco, M., Siena, S., Mecucci, C., and Gilliland, D. G. H4(10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived β receptor (PDGFβR) in atypical chronic myeloid leukemia with a t(5;10)(q33;q22). Blood, 94 (Suppl. 1): 51a, 1999.
22. Carroll, M., Tomasson, M. H., Barker, G. F., Golub, T. R., and Gilliland, D. G. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. USA, 93: 14845-14850, 1996.
23. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60: 557-563, 1990.
24. Pierotti, M. A., Santoro, M., Jenkins, R. B., Sozzi, G., Bongarzone, I., Grieco, M., Monzini, N., Miozzo, M., Herrmann, M. A., Fusco, A., Hay, I. D., Dellaporta, G., and Vecchio, G. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl. Acad. Sci. USA, 89: 1616-1620, 1992.
25. Jhiang, S. M., Sagartz, J. E., Tong, Q., Parker Thornburg, J., Capen, C. C., Cho, J. Y., Xing, S., and Ledent, C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology, 137: 375-378, 1996.
26. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., and Mariame, B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood. 93: 3088-3095, 1999.
27. Knezevich, S. R., McFadden, D. E., Tao, W., Lim, J. F., and Sorensen, P. H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet., 18: 184-187, 1998.
28. Eguchi, M., Eguchi Ishimae, M., Tojo, A., Morishita, K., Suzuki, K., Sato, Y., Kudoh, S., Tanaka, K., Setoyama, M., Nagamura, F., Asano, S., and Kamada, N. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12; 15)(p13;q25). Blood, 93: 1355-1363, 1999.
29. Tong, Q., Xing, S., and Jhiang, S. M. Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity. J. Biol. Chem., 272: 9043-9047, 1997.
30. Berkowicz, M., Rosner, E., Rechavi, G., Mamon, Z., Neuman, Y., Ben Bassat, I., and Ramot, B. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12): a new association. Cancer Genet. Cytogenet., 51: 277-278, 1991.
31. Wessels, J. W., Fibbe, W. E., van der Keur, D., Landegent, J. E., van der Plas, D. C., den Ottolander, G. J., Roozendaal, K. J., and Beverstock, G. C. t(5;12)(q31;p12): a clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genet. Cytogenet., 65: 7-11, 1993.
32. Bain, B. J. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Br. J. Haematol., 95: 2-9, 1996.
33. Abe, A., Tanimoto, M., Towatari, M., Matsuoka, A., Kitaori, K., Kato, H., Toyozumi, H., Takeo, T., Adachi, K., Emi, N., Kawashima, K., and Saito, H. Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5. Cancer Genet. Cytogenet., S3: 37-41, 1995.
34. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., and Grosveld, G. Structural organization of the bcr gene and its role in the Ph′ translocation. Nature (Lond.), 315: 758-761, 1985.
35. Shtivelman, E., Lifshitz, B., Gale, R. P., and Canaani, E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (Lond.), 315: 550-554, 1985.
36. Andreasson, P., Johansson, B., Carlsson, M., Jarlsfelt, I., Fioretos, T., Mitelman, F., and Hoglund, M. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer, 20: 299-304, 1997.
37. Lacronique, V., Boureux, A., Valle, V. D., Poirel, H., Quang, C. T., Mauchauffe, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., and Bernard, O. A. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science (Washington DC), 278: 1309-1312, 1997.
38. Xiao, S., Nalabolu, S. R., Aster, J. C., Ma, J., Abruzzo, L., Jaffe, E. S., Stone, R., Weissman, S. M., Hudson, T. J., and Fletcher, J. A. FGFR1 is fused with a novel zinc-finger gene, ZNF198. in the t(8;13) leukaemia/lymphoma syndrome. Nat. Genet., 18: 84-87, 1998.
39. Popovici, C., Adelaide, J., Ollendorff, V., Chaffanet, M., Guasch, G., Jacrot, M., Leroux, D., Birnbaum, D., and Pebusque, M. J. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8; 13). Proc. Natl. Acad. Sci. USA, 95: 5712-5717, 1998.
40. Popovici, C., Zhang, B., Gregoire, M. J., Jonveaux, P., Lafage Pochitaloff, M., Birnbaum, D., and Pebusque, M. J. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood, 93: 1381-1389, 1999.
41. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (Washington DC), 263: 1281-1284, 1994.
42. Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., Delsol, G., and Campo E. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood, 94: 3265-3268, 1999.
43. Ma, Z., Cools, J., Marynen, P., Cui, X., Siebert, R., Gesk, S., Schlegelberger, B., Peeters, B., De Wolf-Peeters, C., Wlodarska, I., and Morris, S. W. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood, 95: 2144-2149, 2000.
44. Cazzaniga, G., Tosi, S., Aloisi, A., Giudici, G., Daniotti, M., Pioltelli, P., Kearney, L., and Biondi, A. The tyrosine kinase Abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts. Blood, 94: 4370-4373, 1999.